Three Leaders In mRNA Therapeutics

Source: Cytiva

In this segment of the Bioprocess Online Live event mRNA Manufacturing: Bright Future, Big Challenges, we get to know leaders at three organizations bringing mRNA technology to bear in a variety of prophylactic and therapeutic capacities. Tune in and get to know Roberta Duncan, VP of the mRNA program at Seqirus; Duke Human Vaccine Institute Associate Director of Upstream and Downstream Process Development Jason Dickens, Ph.D.; and Jin Zhou, Executive Director of Process Development for mRNA and Protein Biologics at Ultragenyx.

View the full presentation on-demand here.


access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online